{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:48:56Z","timestamp":1774442936945,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T00:00:00Z","timestamp":1627689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T00:00:00Z","timestamp":1627689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00428-021-03171-w","type":"journal-article","created":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T04:14:59Z","timestamp":1627704899000},"page":"883-891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["MicroRNA-21 expression in cancer cells is an independent biomarker of progression-free survival of endometrioid endometrial carcinoma"],"prefix":"10.1007","volume":"479","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8534-8852","authenticated-orcid":false,"given":"Kimiya","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morikazu","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Takano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,31]]},"reference":[{"key":"3171_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69\u201390","journal-title":"CA Cancer J Clin"},{"key":"3171_CR2","volume-title":"Female Genital Tumours (WHO Classification of Tumours)","author":"WHO Classification of Tumours Editorial Board","year":"2020","unstructured":"WHO Classification of Tumours Editorial Board (2020) Female Genital Tumours (WHO Classification of Tumours). IARC Press, Lyon"},{"key":"3171_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","volume":"15","author":"JV Bokhman","year":"1983","unstructured":"Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15:10\u201317","journal-title":"Gynecol Oncol"},{"key":"3171_CR4","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nrg2634","volume":"10","author":"CM Croce","year":"2009","unstructured":"Croce CM (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10:704\u2013714","journal-title":"Nat Rev Genet"},{"key":"3171_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.omtn.2020.03.003","volume":"20","author":"D Bautista-S\u00e1nchez","year":"2020","unstructured":"Bautista-S\u00e1nchez D, Arriaga-Canon C, Pedroza-Torres A et al (2020) The promising role of miR-21 as a cancer biomarker and its importance in RNA-based therapeutics. Mol Ther Nucleic Acids 20:409\u2013420","journal-title":"Mol Ther Nucleic Acids"},{"key":"3171_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11060-012-0992-3","volume":"111","author":"SK Hermansen","year":"2013","unstructured":"Hermansen SK, Dahlrot RH, Nielsen BS, Hansen S, Kristensen BW (2013) MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas. J Neurooncol 111:71\u201381","journal-title":"J Neurooncol"},{"key":"3171_CR7","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1007\/s11605-008-0584-x","volume":"12","author":"M Dillhoff","year":"2008","unstructured":"Dillhoff M, Liu J, Frankel W, Croce C, Bloomston M (2008) MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J Gastrointest Surg 12:2171\u20132176","journal-title":"J Gastrointest Surg"},{"key":"3171_CR8","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1158\/1078-0432.CCR-08-3257","volume":"15","author":"N Yamamichi","year":"2009","unstructured":"Yamamichi N, Shimomura R, Inada K et al (2009) Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development. Clin Cancer Res 15:4009\u20134016","journal-title":"Clin Cancer Res"},{"key":"3171_CR9","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1600-0463.2011.02782.x","volume":"119","author":"L Rask","year":"2011","unstructured":"Rask L, Balslev E, Jorgensen S et al (2011) High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer. APMIS 119:663\u2013673","journal-title":"APMIS"},{"key":"3171_CR10","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/jjco\/hyt084","volume":"43","author":"Y Wang","year":"2013","unstructured":"Wang Y, Li J, Tong L et al (2013) The prognostic value of miR-21 and miR-155 in non-small-cell lung cancer: a meta-analysis. Jpn J Clin Oncol 43:813\u2013820","journal-title":"Jpn J Clin Oncol"},{"key":"3171_CR11","first-page":"3066","volume":"17","author":"Y Wang","year":"2019","unstructured":"Wang Y, Zhou S, Fan K, Jiang C (2019) MicroRNA-21 and its impact on signaling pathways in cervical cancer. Oncol Lett 17:3066\u20133070","journal-title":"Oncol Lett"},{"key":"3171_CR12","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.3892\/ol.2012.896","volume":"4","author":"X Qin","year":"2012","unstructured":"Qin X, Yan L, Zhao X, Li C, Fu Y (2012) microRNA-21 overexpression contributes to cell proliferation by targeting PTEN in endometrioid endometrial cancer. Oncol Lett 4:1290\u20131296","journal-title":"Oncol Lett"},{"key":"3171_CR13","first-page":"11489","volume":"10","author":"W Zhao","year":"2017","unstructured":"Zhao W, Geng P, Li Y, Wei X, Cheng J (2017) MicroRNA-21 promotes endometrial carcinoma proliferation and invasion by targeting PTEN. Int J Clin Exp Pathol 10:11489\u201311495","journal-title":"Int J Clin Exp Pathol"},{"key":"3171_CR14","doi-asserted-by":"publisher","first-page":"68894","DOI":"10.18632\/oncotarget.12028","volume":"7","author":"Y Gao","year":"2016","unstructured":"Gao Y, Dai M, Liu H et al (2016) Diagnostic value of circulating miR-21: an update meta-analysis in various cancers and validation in endometrial cancer. Oncotarget 7:68894\u201368908","journal-title":"Oncotarget"},{"key":"3171_CR15","first-page":"1897","volume":"43","author":"C Wang","year":"2020","unstructured":"Wang C, Li Q, He Y (2020) MicroRNA-21-5p promotes epithelial to mesenchymal transition by targeting SRY-box 17 in endometrial cancer. Oncol Rep 43:1897\u20131905","journal-title":"Oncol Rep"},{"key":"3171_CR16","doi-asserted-by":"publisher","first-page":"e0156919","DOI":"10.1371\/journal.pone.0156919","volume":"11","author":"AH Eriksen","year":"2016","unstructured":"Eriksen AH, Andersen RF, Nielsen BS et al (2016) Intratumoral heterogeneity of microRNA expression in rectal cancer. PLoS One 11:e0156919","journal-title":"PLoS One"},{"key":"3171_CR17","doi-asserted-by":"publisher","first-page":"e0179113","DOI":"10.1371\/journal.pone.0179113","volume":"12","author":"AH Zedan","year":"2017","unstructured":"Zedan AH, Blavnsfeldt SG, Hansen TF et al (2017) Heterogeneity of miRNA expression in localized prostate cancer with clinicopathological correlations. PLoS One 12:e0179113","journal-title":"PLoS One"},{"key":"3171_CR18","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1093\/nar\/gni178","volume":"33","author":"C Chen","year":"2005","unstructured":"Chen C, Ridzon DA, Broomer AJ et al (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33:e179","journal-title":"Nucleic Acids Res"},{"key":"3171_CR19","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00432-011-1140-8","volume":"138","author":"Z Cao","year":"2012","unstructured":"Cao Z, Yoon JH, Nam SW, Lee JY, Park WS (2012) PDCD4 expression inversely correlated with miR-21 levels in gastric cancers. J Cancer Res Clin Oncol 138:611\u2013619","journal-title":"J Cancer Res Clin Oncol"},{"key":"3171_CR20","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1261\/rna.939908","volume":"14","author":"HJ Peltier","year":"2008","unstructured":"Peltier HJ, Latham GJ (2008) Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14:844\u2013852","journal-title":"RNA"},{"key":"3171_CR21","first-page":"360","volume":"37","author":"AJ Viera","year":"2005","unstructured":"Viera AJ, Garrett JM (2005) Understanding interobserver agreement: the kappa statistic. Fam Med 37:360\u2013363","journal-title":"Fam Med"},{"key":"3171_CR22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 22:276\u2013282","journal-title":"Biochem Med (Zagreb)"},{"key":"3171_CR23","doi-asserted-by":"publisher","first-page":"e71978","DOI":"10.1371\/journal.pone.0071978","volume":"8","author":"BE Kadera","year":"2013","unstructured":"Kadera BE, Li L, Toste PA et al (2013) MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis. PLoS One 8:e71978","journal-title":"PLoS One"},{"key":"3171_CR24","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/his.12491","volume":"65","author":"H Uozaki","year":"2014","unstructured":"Uozaki H, Morita S, Kumagai A et al (2014) Stromal miR-21 is more important than miR-21 of tumour cells for the progression of gastric cancer. Histopathology 65:775\u2013783","journal-title":"Histopathology"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-021-03171-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-021-03171-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-021-03171-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T02:03:55Z","timestamp":1636337035000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-021-03171-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,31]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["3171"],"URL":"https:\/\/doi.org\/10.1007\/s00428-021-03171-w","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,31]]},"assertion":[{"value":"27 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research protocol was approved by the Institutional Ethical Review Board Committee of the National Defense Medical College, Tokorozawa, Japan (Reference No. 3004).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}